Investment boosts SpheriTech’s growth

07-Jan-2010 - SpheriTech received a six-figure investment has come from a financial backer who wishes to remain anonymous. The investor has taken a 20% holding in SpheriTech. Launched as a one-man operation by founder and chief executive Don Wellings, the company has already used the new investment to employ a ...

Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects

27-Nov-2009 - Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products. Under the ...

Plant Impact plc Signs R&D Collaboration Agreement with CEM Analytical Services Ltd and tecsolve (UK) Ltd

16-Jun-2009 - Plant Impact announced that as part of an ongoing strategic review of its activities, and in light of the successful completion of the commercialisation deal with Arysta Life Science Corporation, it has signed long term agreements with tecsolve and CEMAS. The Agreements, which are effective as ...

Antaria and Merck sign licensing agreement

07-May-2009 - Merck KGaA announced it has executed a licensing agreement with Antaria Limited, Australia, for the exclusive worldwide rights to Antaria’s plate-like alumina technology. The technology from Antaria is used in Alusion®, a functional filler that gives cosmetics soft focus properties, among other ...

Molecular Profiles Introduces New Nanoscale Predictive Analytical Screening Solution for APIs

24-Jan-2008 - Molecular Profiles, provider of contract research services to the pharmaceutical, biopharmaceutical and biomedical sectors, announcds the latest addition to its comprehensive nanoscale analytical services offering, nanoPASS (nanoscale Predictive Analytical Screening Solution). According to the ...

i3 announces next phase of strategic global expansion

11-Dec-2006 - Pharmaceutical services company i3 announced the next phase of its global expansion, which includes organic and acquired growth in India, Latin America, and Eastern and Western Europe. Coupled with important acquisitions earlier this year in Canada and Asia/Pacific, these additions to the i3 ...

Amarin Announces Appointment of Dr. John Climax as Non-Executive Director

23-Mar-2006 - Amarin Corporation plc announced the appointment of Dr. John Climax as non-executive director. Dr. Climax was a founder of ICON Clinical Research plc, serving as a Director and Chief Executive Officer of ICON and its subsidiaries since June 1990. In November 2002, he was appointed Executive ...

Matrix acquires 43 % stake in Explora, Switzerland.

Strategic initiative to gain access to technology platforms and product portfolios such as anti-cancer and corticosteroids

23-Sep-2005 - Matrix Laboratories Limited announced that it has acquired 43 per cent stake in Explora Laboratories S.A, a technology platform company based in Mendrisio, Switzerland. Explora Laboratories is engaged in the research and development (R&D) of Active Pharmaceutical Ingredients (APIs) and ...

Cost-effective R&D Outsourcing Attracts Global Pharmaceutical Industry to India and China

Research Standards Set to be International; Government Regulations Encourage Outsourcing

05-Sep-2005 - The rise of India and China as global economies presents immense opportunities for the international pharmaceutical industry. Besieged by ever-increasing cost pressures, shorter product life cycles and numerous regulatory challenges in the West, the industry is increasingly shifting its research ...

Thermo Electron Corporation purchased Ionalytics Corporation

15-Aug-2005 - Thermo Electron Corporation announced that it has purchased Ionalytics Corporation, developer of a dynamic ion filtering device used with mass spectrometers in bioanalysis, proteomics and drug discovery. Financial terms of the transaction were not disclosed. Founded in 2001, as a spin out from ...